Search Results - "María Isabel Martín Herranz"

Refine Results
  1. 1
  2. 2

    Management of Everolimus and Voriconazole Interaction in Lung Transplant Patients by Outeda Macías, María, Salvador Garrido, Pilar, Elberdín Pazos, Laida, Martín Herranz, María Isabel

    Published in Therapeutic drug monitoring (01-06-2016)
    “…To analyze the impact of voriconazole administration on everolimus dose, trough concentrations and concentration/dose (C0/D) ratio in order to determine the…”
    Get full text
    Journal Article
  3. 3

    Analysing Early Diagnosis Strategies for HIV Infection: A Retrospective Study of Missed Diagnostic Opportunities by Giménez-Arufe, Víctor, Rotea-Salvo, Sandra, Martínez-Pradeda, Alejandro, Mena-de-Cea, Álvaro, Margusino-Framiñán, Luis, Suanzes-Hernández, Jorge, Martín Herranz, María Isabel, Cid-Silva, Purificación

    Published in Healthcare (Basel) (01-01-2024)
    “…Early diagnosis of a Human Immunodeficiency Virus (HIV)-infected person represents a cornerstone of HIV prevention, treatment, and care. Numerous publications…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Experience with Levosimendan in 32 Paediatric Patients by Vilaboa Pedrosa, Clara, Martínez Roca, Cristina, Yáñez Gómez, Pedro, Martín Herranz, María Isabel

    Published in Pediatric cardiology (01-06-2015)
    “…The aim of this study was to describe the off-label conditions of use for levosimendan in the paediatric population of a tertiary referral hospital. This is a…”
    Get full text
    Journal Article
  6. 6

    Coronary vascular disease event risk and metabolic syndrome prevalence in patients enrolled in an assertive treatment community program by Ramudo Cela, Luis, Ávila González, María José, Yáñez Rubal, Juan Carlos, Díaz Platas, Lucía María, Martín Herranz, María Isabel, Díaz del Valle, Juan Carlos

    Published in Comprehensive psychiatry (01-02-2018)
    “…To examine the risk of coronary vascular disease event (CVDE) and the prevalence metabolic syndrome (MS) and its cardiovascular risk factors (CVRF) in patients…”
    Get full text
    Journal Article
  7. 7

    What is the optimal dose of clopidogrel in paediatric patients? by García, Cristina Mondelo, Roca, Cristina Martínez, Núñez, Fernando Rueda, Herranz, María Isabel Martín

    Published in Anales de Pediatría (01-04-2019)
    “…The aim of this study was to collect retrospective data on the prescription of clopidogrel, describe the conditions of its use in the paediatric population of…”
    Get full text
    Journal Article
  8. 8

    Study on adherence to treatment with imatinib in chronic myeloid leukaemia and its association with therapeutic response by García-Queiruga, Marta, María Martínez-López, Laura, Isabel Martín-Herranz, María, Seoane-Pillado, Teresa, Fernández-Gabriel, Elena, Calleja-Chuclá, Teresa

    Published in Farmacia hospitalaria (01-05-2016)
    “…To assess the level of adherence to treatment with imatinib in patients with chronic myeloid leukaemia and its association with therapeutic response. Study…”
    Get full text
    Journal Article
  9. 9

    Cuál es la dosis óptima de clopidogrel en pacientes pediátricos? by Mondelo García, Cristina, Martínez Roca, Cristina, Rueda Núñez, Fernando, Martín Herranz, María Isabel

    “…Resumen Introducción El objetivo de este estudio fue recopilar datos retrospectivos sobre la prescripción de clopidogrel y describir las condiciones de uso en…”
    Get full text
    Journal Article
  10. 10

    Evaluación del cumplimiento del protocolo de utilización de cloruro potásico by Noelia Bargiela Fernández, Pilar Garrido Salvador, Isaura Vázquez Pedreira, Sara Piñeiro González, María Isabel Herránz Martín

    Published in Ars Pharmaceutica (01-06-2017)
    “…RESUMEN Objetivo: Analizar el grado de cumplimiento del “Protocolo de Utilización de Cloruro potásico” implantado en nuestro hospital, mediante la realización…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Evaluación del cumplimiento del protocolo de utilización de cloruro potásico by Fernández Bargiela, Noelia, Salvador Garrido, Pilar, Pedreira Vázquez, Isaura, González Piñeiro, Sara, Martín Herránz, María Isabel

    Published in Ars pharmaceutica (20-06-2017)
    “…Objetivo: Analizar el grado de cumplimiento del “Protocolo de Utilización de Cloruro potásico” implantado en nuestro hospital, mediante la realización de…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Dalbavancin as consolidation therapy for infective endocarditis in patients with comorbidity. A real world experience by Brandariz-Núñez, D, Luances-Rodríguez, A, Feijoo-Vilanova, P, Gutiérrez-Urbón, J M, Ramudo-Cela, L, Martín-Herranz, M I, Margusino-Framiñán, L

    Published in Revista española de quimioterapia (01-08-2024)
    “…Infective endocarditis (IE) is a potentially life-threatening infection, the incidence of which has in creased in recent decades, particularly among elderly…”
    Get full text
    Journal Article
  16. 16

    Prevalence of adverse drug reactions associated with emergency department visits and risk factors for hospitalization by Brandariz-Núñez, David, Ferreiro-Gómez, Manuel, Suanzes, Jorge, Margusino-Framiñán, Luis, De la Cámara-Gómez, María, Fandiño-Orgueira, José Manuel, Martín-Herranz, María Isabel

    Published in Farmacia hospitalaria (01-01-2023)
    “…Adverse drug reactions increase morbidity and mortality, prolong hospital stay and increase healthcare costs. The primary objective of this study was to…”
    Get full text
    Journal Article
  17. 17

    What is the optimal dose of clopidogrel in paediatric patients? by Cristina Mondelo García, Cristina Martínez Roca, Fernando Rueda Núñez, María Isabel Martín Herranz

    Published in Anales de Pediatría (01-04-2019)
    “…Introduction: The aim of this study was to collect retrospective data on the prescription of clopidogrel, describe the conditions of its use in the paediatric…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20